Skip to main content
Premium Trial:

Request an Annual Quote

Saad Usmani

Saad Usmani has been appointed Acting CMO of SkylineDx, where he will lead the overall clinical vision of the Dutch cancer molecular diagnostics firm. Usmani is currently the director of clinical research (hematologic malignancies) and director of plasma cell disorders at Carolinas HealthCare System's Levine Cancer Institute. He previously was director of developmental therapeutics at the University of Arkansas.